Roche to acquire Curagen's 454

Roche (SWX:ROG) will acquire CRGN's high throughput genome sequencing subsidiary 454 Life Sciences for $140 million in cash.

Read the full 185 word article

How to gain access

Continue reading with a
two-week free trial.